Nike founder Phil Knight donates $2B to cancer site
The newly independent Oregon cancer site has received a landmark $2B donation from Nike founder Phil Knight, continuing his significant philanthropic efforts.
The newly independent Oregon cancer site has received a landmark $2B donation from Nike founder Phil Knight, continuing his significant philanthropic efforts.
A new ABPI report highlights a worrying lag in UK investment for life sciences, calling for urgent policy changes to secure the nation’s economic future.
The Odyssey saga continues as the company secures a massive $213m series D funding round. Learn how this significant investment will shape their future plans.
Pharmaceutical giant Merck has cancelled its flagship £1b project and is ceasing all R&D operations in the UK, a major blow to the nation’s science sector.
Facing an ongoing tourism decline, Las Vegas casinos are replacing live dealers with electronic table games to cut costs. See how this shift impacts jobs & gaming.
A major bank reportedly processed over $1b in transactions for Jeffrey Epstein, ignoring internal red flags and concerns about the disgraced financier’s activities.
Pharmaceutical giant and Ozempic-maker Novo Nordisk has announced it will cut 9,000 jobs as part of a major global restructuring plan. Find out more here.
AI training startup Mercor eyes a massive $10 billion+ valuation, sources say. The company’s impressive $450 million run rate fuels its ambitious growth plans.
A new report shows golf rounds plunge at U.S. courses as Canadian players appear to be boycotting Trump-era travel. We analyze the economic impact and numbers.
UK higher education is set for a major shake-up as two merge to create the country’s first ‘super-university’. This new powerhouse is scheduled to launch in 2026.